Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Vaccines
Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence
Sariya Udayachalerma University of Utah College of Pharmacy, Salt Lake City, UT, USA
https://orcid.org/0000-0002-9762-5466
https://orcid.org/0000-0002-9762-5466, , Thunyarat Anothaisintaweeb Department of Family Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailandhttps://orcid.org/0000-0003-1002-8536
https://orcid.org/0000-0003-1002-8536, Ammarin Thakkinstianc Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailandhttps://orcid.org/0000-0001-9991-386X
https://orcid.org/0000-0001-9991-386X, Sajesh K. Veettila University of Utah College of Pharmacy, Salt Lake City, UT, USAhttps://orcid.org/0000-0002-7009-7907
https://orcid.org/0000-0002-7009-7907 & Nathorn Chaiyakunapruka University of Utah College of Pharmacy, Salt Lake City, UT, USA;d School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USACorrespondence[email protected]
https://orcid.org/0000-0003-4572-8794
https://orcid.org/0000-0003-4572-8794Related Research Data
Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence
Source:
Taylor & Francis
Linking provided by
